Frontline Treatment Selection and Shared Decision-Making

Dr. Zeidner explores frontline treatment selection strategies, emphasizing the abundance of oral options available at diagnosis and sequencing possibilities throughout patient treatment courses. Current options include imatinib, second-generation agents (dasatinib, nilotinib), third-generation bosutinib, and asciminib, providing extensive therapeutic flexibility for diverse patient populations.

Dr. Cortes emphasizes comprehensive initial consultations involving detailed disease education, pathophysiology explanation, risk assessment, monitoring strategies, and goal clarification. Many patients present asymptomatically, requiring explanation of treatment necessity despite symptom absence. Eventually, treatment-related side effects may represent patients' primary disease experience, making goal understanding crucial for long-term adherence and engagement.

Shared decision-making incorporates individual patient preferences including dosing schedules, fasting requirements, and lifestyle considerations. The therapeutic abundance allows personalized approaches accommodating patient-specific factors while optimizing efficacy outcomes. Dr. Cortes advocates against prescriptive approaches, preferring collaborative discussions explaining rationale and options to engage patients as active participants in treatment selection.

Both physicians acknowledge variable patient education levels and consultation quality across practice settings, noting some patients receive minimal information about treatment options or disease biology. They emphasize the need for improved patient education standards and comprehensive discussions regardless of practice environment or time constraints.

Dr. Zeidner highlights that approximately 50% to 60% of patients present asymptomatically with incidental white count elevation prompting further evaluation, whereas others experience gradual symptom onset including splenomegaly, constitutional symptoms, or other manifestations. This presentation variability influences initial discussion approaches and patient understanding of treatment urgency and necessity for immediate intervention.